PedAM
Pediatric Disease Annotations & Medicines
| Disease | irritable bowel syndrome |
| Phenotype | C0021390|inflammatory bowel disease |
| Sentences | 9 |
| PubMedID- 20389294 | irritable bowel syndrome-type symptoms in patients with inflammatory bowel disease: a real association or reflection of occult inflammation. |
| PubMedID- 25580205 | Background: faecal calprotectin (fc), a cytosolic protein released by neutrophils (s100 family) in response to inflammation, is a simple, non-invasive test that can be used to differentiate irritable bowel syndrome (ibs) with inflammatory bowel disease (ibd), where there can be considerable symptom overlap. |
| PubMedID- 23855395 | Commentary: symptoms of irritable bowel syndrome in patients with inflammatory bowel disease--organic disease or diseased organ. |
| PubMedID- 26426460 | irritable bowel syndrome in patients with quiescent inflammatory bowel disease. |
| PubMedID- 23668698 | Symptoms of irritable bowel syndrome in patients with inflammatory bowel disease: examining the role of sub-clinical inflammation and the impact on clinical assessment of disease activity. |
| PubMedID- 23731196 | Background: gastrointestinal symptoms compatible with irritable bowel syndrome (ibs) are common in patients with inflammatory bowel disease. |
| PubMedID- 24417262 | The nature and clinical implications of irritable bowel syndrome (ibs)-type symptoms in patients with inflammatory bowel disease (ibd) who are in apparent remission have generated considerable debate. |
| PubMedID- 25855880 | This has been used to distinguish patients exhibiting symptoms of irritable bowel syndrome from patients with inflammatory bowel disease, with a measure of success greater than with currently used techniques. |
| PubMedID- 21292684 | Managing symptoms of irritable bowel syndrome in patients with inflammatory bowel disease. |
Page: 1